- Home
- TCMD vs AMLX Comparison
TCMD vs AMLX Comparison
Compare TCMD & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCMD
- AMLX
- Stock Information
- Founded
- TCMD 1995
- AMLX 2014
- Country
- TCMD United States
- AMLX United States
- Employees
- TCMD N/A
- AMLX N/A
- Industry
- TCMD Medical/Dental Instruments
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- TCMD Health Care
- AMLX Health Care
- Exchange
- TCMD Nasdaq
- AMLX Nasdaq
- Market Cap
- TCMD 314.0M
- AMLX 330.5M
- IPO Year
- TCMD 2016
- AMLX 2022
- Fundamental
- Price
- TCMD $9.54
- AMLX $4.61
- Analyst Decision
- TCMD Hold
- AMLX Buy
- Analyst Count
- TCMD 3
- AMLX 5
- Target Price
- TCMD $16.00
- AMLX $9.60
- AVG Volume (30 Days)
- TCMD 317.5K
- AMLX 1.0M
- Earning Date
- TCMD 05-05-2025
- AMLX 05-08-2025
- Dividend Yield
- TCMD N/A
- AMLX N/A
- EPS Growth
- TCMD N/A
- AMLX N/A
- EPS
- TCMD 0.66
- AMLX N/A
- Revenue
- TCMD $293,164,000.00
- AMLX N/A
- Revenue This Year
- TCMD $10.68
- AMLX N/A
- Revenue Next Year
- TCMD $8.82
- AMLX N/A
- P/E Ratio
- TCMD $14.45
- AMLX N/A
- Revenue Growth
- TCMD 5.96
- AMLX N/A
- 52 Week Low
- TCMD $8.61
- AMLX $1.58
- 52 Week High
- TCMD $21.10
- AMLX $7.27
- Technical
- Relative Strength Index (RSI)
- TCMD 20.45
- AMLX 52.12
- Support Level
- TCMD $8.61
- AMLX $4.65
- Resistance Level
- TCMD $14.22
- AMLX $5.34
- Average True Range (ATR)
- TCMD 0.48
- AMLX 0.44
- MACD
- TCMD -0.51
- AMLX -0.07
- Stochastic Oscillator
- TCMD 15.50
- AMLX 25.98
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.